Valiant Laboratories per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024
₹2.95−₹0.51−₹0.51₹0.13
₹2.84−₹0.51−₹0.51₹0.13
₹57.24₹57.24₹53.93₹54.51
₹56.33₹43.72₹30.70₹41.90
—−₹1.92₹0.30₹0.43
−₹8.22−₹8.22−₹25.90−₹10.12
5.45.44.34.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VALIANTLAB₹125.82

Valiant Laboratories Limited

· Pharma & Health
₹ CrorePeersALBERTDAVDHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹683 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS0.13-0.51-0.512.95
Diluted EPS0.13-0.51-0.512.84
Book Value per Share54.5153.9357.2457.24
Revenue per Share41.9030.7043.7256.33
Cash Flow per Share0.430.30-1.92—
Free Cash Flow per Share-10.12-25.90-8.22-8.22
Shares Outstanding (cr)4.34.35.45.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.